image_alt_text
3

Jianmin Cui, Ph.D.

AIMBE College of Fellows Class of 2016
For outstanding contributions to the field of molecular and cellular bioengineering

Compound may prevent risk of form of arrhythmia from common medications

Via Washington University in St. Louis | May 17, 2021

Dozens of commonly used drugs, including antibiotics, anti-nausea and anticancer medications, have a potential side effect of lengthening the electrical event that triggers contraction, creating an irregular heartbeat, or cardiac arrhythmia called acquired Long QT syndrome. While safe in their current dosages, some of these drugs may have a more therapeutic benefit at higher doses, but are limited by the risk of arrhythmia.

Through both computational and experimental validation, a multi-institutional team of researchers has identified a compound that prevents the lengthening of the heart’s electrical event, or action potential, resulting in a major step toward safer use and expanded therapeutic efficacy of these medications when taken in combination… Continue reading.

An ‘unprecedented look’ into the protein behind hypertension, epilepsy and other conditions

Via Washington University in St. Louis | May 14, 2018

The seemingly unrelated conditions of hypertension, epilepsy and overactive bladder may be linked by electrical activity in a protein long studied by a biomedical engineer at Washington University in St. Louis.

After new technology recently revealed the structure of the protein, the lab of Jianmin Cui, professor of biomedical engineering in the School of Engineering & Applied Science, will collaborate with two others to take an unprecedented look into its molecular mechanisms potentially leading to the development of new drugs for these and other conditions.

Cui has received a four-year, $2.9 million grant from the National Institutes of Health to study the BK (big potassium) channel proteins in collaboration with labs from the University of Missouri-Columbia and the University of Massachusetts. The labs will each play a role in identifying new compounds that could go into the drug development pipeline… Continue reading.

Jianmin Cui, Ph.D. To be Inducted into Medical and Biological Engineering Elite

Via AIMBE | January 20, 2016

WASHINGTON, D.C.— The American Institute for Medical and Biological Engineering (AIMBE) has announced the pending induction of Jianmin Cui, Ph.D., Professor of Biomedical Engineering on the Endowment of Spencer T. Olin., Biomedical Engineering, Washington University in St. Louis, to its College of Fellows. Dr. Cui was nominated, reviewed, and elected by peers and members of the College of Fellows For outstanding contributions to the field of molecular and cellular bioengineering.